Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Zymeworks Raises $100M Via Equity Issued At 14% Discount

Zymeworks Inc (NYSE:ZYME) has priced its underwritten public offering of 9.16 million common shares, pre-funded warrants to purchase up to 3.34 million shares. 

  • The shares are offered at $8.00 per common share and the pre-funded warrants at $7.9999 per pre-funded warrant. 
  • The offer price represents a discount of almost 14% from the last close price of $9.32 on Wednesday.
  • See the offer prospectus here.
  • The gross proceeds to Zymeworks are expected to be approximately $100.0 million. 
  • Underwriters have an option to purchase up to an additional 1.875 million shares.
  • The Company will use the proceeds to develop zanidatamab, adaptive Phase 1 trials of ZW49, and for general corporate purposes.
  • Related: Zymeworks To Cut Its Workforce By Almost 25%, Outlines 2022 & 2023 Priorities.
  • The offering is expected to close by January 31.
  • Price Action: ZYME shares are down 11.5% at $8.25 during the premarket session on the last check Thursday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.